These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 87927)

  • 61. Long-term treatment of onchocerciasis patients from the Liberian rain-forest with low doses of diethylcarbamazine citrate after complete nodulectomy.
    Albiez EJ
    Tropenmed Parasitol; 1983 Dec; 34(4):267-70. PubMed ID: 6420965
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Accidental exposure to sarin: vision effects.
    Rengstorff RH
    Arch Toxicol; 1985 Jan; 56(3):201-3. PubMed ID: 3977601
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
    Daneshvar H; Racette L; Coupland SG; Kertes PJ; Guberman A; Zackon D
    Ophthalmology; 1999 Sep; 106(9):1792-8. PubMed ID: 10485552
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diethylcarbamazine citrate lotion and onchocerciasis.
    Lancet; 1980 Dec; 2(8206):1232-3. PubMed ID: 6108401
    [No Abstract]   [Full Text] [Related]  

  • 65. Studies on Bancroftian filariasis in Liberia, West Africa. IV. Notes on side effects observed during a diethylcarbamazine treatment campaign in a rural area endemic for Wuchereria bancrofti and Onchocerca volvulus.
    Chlebowsky HO; Zielke E
    Tropenmed Parasitol; 1980 Sep; 31(3):339-44. PubMed ID: 7003853
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Onchocerciasis.
    Duke BO
    Br Med J; 1968 Nov; 4(5626):301-4. PubMed ID: 5687973
    [No Abstract]   [Full Text] [Related]  

  • 67. [Vigabatrin and visual fields defects].
    Jensen K
    Ugeskr Laeger; 2001 Jan; 163(2):184. PubMed ID: 11379251
    [No Abstract]   [Full Text] [Related]  

  • 68. The chemotherapy of onchocerciasis iii. A comparative study of diethylcarbamazide (DEC) and metrifonate.
    Awadzi K; Gilles HM
    Ann Trop Med Parasitol; 1980 Apr; 74(2):199-210. PubMed ID: 7002074
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Visual dysfunction and methotrexate.
    Johansson B
    Acta Ophthalmol Scand; 2004 Oct; 82(5):625. PubMed ID: 15453868
    [No Abstract]   [Full Text] [Related]  

  • 70. Diagnostic and therapeutic challenges.
    Tranos PG; Moore A; Pavesio C; Acharya NR; Johnson MW
    Retina; 2012 Jan; 32(1):191-6. PubMed ID: 21886020
    [No Abstract]   [Full Text] [Related]  

  • 71. [Treatment of onchocerciasis with diethylcarbamazine and moranil in nonimmune persons].
    Firsova RA; Ozeretskovskaia NN; Kulinich GV; Supriaga VG; Mikhaĭlova VA
    Med Parazitol (Mosk); 1982; 51(5):33-5. PubMed ID: 7185365
    [No Abstract]   [Full Text] [Related]  

  • 72. Vigabatrin-associated visual field loss.
    Fecarotta C; Sergott RC
    Int Ophthalmol Clin; 2012; 52(3):87-94, xii. PubMed ID: 22668542
    [No Abstract]   [Full Text] [Related]  

  • 73. Vigabatrin and visual field disorders.
    Prescrire Int; 2002 Dec; 11(62):182. PubMed ID: 12472095
    [No Abstract]   [Full Text] [Related]  

  • 74. [Pharmacokinetics of onchocerciasis preparations. 3. Diethylcarbamazine].
    Lur'e AA; Ovusu A; Ozeretskovskaia NN
    Med Parazitol (Mosk); 1988; (2):41-6. PubMed ID: 3412242
    [No Abstract]   [Full Text] [Related]  

  • 75. Topical diethylcarbamazine in the treatment of ocular onchocerciasis.
    Lazar M; Lieberman TW; Leopold IH
    Am J Trop Med Hyg; 1970 Mar; 19(2):232-3. PubMed ID: 5443071
    [No Abstract]   [Full Text] [Related]  

  • 76. Clinical and laboratory changes consequent to diethylcarbamazine in patients with onchocerciasis.
    Fazen LE; Anderson RI; Fazen LE; Marroquin HF
    Am J Trop Med Hyg; 1976 Mar; 25(2):250-6. PubMed ID: 1259086
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Topical diethylcarbamazine in ocular onchocerciasis.
    Aviel E; David R
    Isr J Med Sci; 1972; 8(8):1166-8. PubMed ID: 4647766
    [No Abstract]   [Full Text] [Related]  

  • 78. Miotic drugs: a review of ocular, visual, and systemic complications.
    Rengstorff R; Royston M
    Am J Optom Physiol Opt; 1976 Feb; 53(2):70-80. PubMed ID: 1084694
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quantification of the ocular reactions to microfilaricides in the chemotherapy of onchocerciasis.
    Hero M; Bird AC; Awadzi K
    Eye (Lond); 1992; 6 ( Pt 1)():93-6. PubMed ID: 1426410
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Visual field constriction on vigabatrin.
    Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.